Cargando…

Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients

The purpose of this work was to analyse the ability of p53 and thymidilate synthase (TS) primary tumour expression to retrospectively predict clinical response to chemotherapy and long-term prognosis in patients with advanced colorectal cancers homogeneously treated by methotrexate (MTX)-modulated–5...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paradiso, A, Simone, G, Petroni, S, Leone, B, Vallejo, C, Lacava, J, Romero, A, Machiavelli, M, Lena, M De, Allegra, C J, Johnston, P G
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363320/ https://www.ncbi.nlm.nih.gov/pubmed/10682666 http://dx.doi.org/10.1054/bjoc.1999.0964

Ejemplares similares

Expression of apoptosis-related markers and clinical outcome in patients with advanced colorectal cancer
por: Paradiso, A, et al.
Publicado: (2001)

Design of Thymidine Analogues Targeting Thymidilate Kinase of Mycobacterium tuberculosis
por: Owono Owono, Luc Calvin, et al.
Publicado: (2013)

The prognostic significance of genetic polymorphisms (Methylenetetrahydrofolate Reductase C677T, Methionine Synthase A2756G, Thymidilate Synthase tandem repeat polymorphism) in multimodally treated oesophageal squamous cell carcinoma
por: Sarbia, M, et al.
Publicado: (2006)

Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma
por: Wong, N A C S, et al.
Publicado: (2001)

A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil
por: Etienne, M C, et al.
Publicado: (1999)

Chronic hypoxia modulates tumour cell radioresponse through cytokine-inducible nitric oxide synthase
por: Berge, D L Van den, et al.
Publicado: (2001)

A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts
por: Pratesi, G, et al.
Publicado: (1999)

Expression of the novel tumour suppressor p33(ING1) is independent of p53
por: Cheung, K-J J, et al.
Publicado: (2000)

Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis
por: Abudu, A, et al.
Publicado: (1999)

Activation and activities of the p53 tumour suppressor protein
por: Bálint, É, et al.
Publicado: (2001)

Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions
por: de Wilt, J H W, et al.
Publicado: (2000)

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
por: Tannapfel, A, et al.
Publicado: (1999)

Identification of tumour-associated and germ line p53 mutations in canine mammary cancer
por: Veldhoen, N, et al.
Publicado: (1999)

Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells
por: Pruschy, M, et al.
Publicado: (1999)

Minisatellite instability is found in colorectal tumours with mismatch repair deficiency
por: Coleman, M G, et al.
Publicado: (2001)

Growth dysregulation and p53 accumulation in human primary colorectal cancer
por: Watson, D S, et al.
Publicado: (1999)

The effect of dose and interval between 5-fluorouracil and leucovorin on the formation of thymidylate synthase ternary complex in human cancer cells.
por: Drake, J. C., et al.
Publicado: (1995)

Frequent loss of expression or aberrant alternative splicing of P2XM, a p53-inducible gene, in soft-tissue tumours
por: Nawa, G, et al.
Publicado: (1999)

Risk factors for testicular germ cell tumours by histological tumour type
por: Coupland, C A C, et al.
Publicado: (1999)

Prostate tumours from an Asian population: examination of bax, bcl-2, p53 and ras and identification of bax as prognostic marker
por: Chia, S-J, et al.
Publicado: (2000)

A phase I study of the lipophilic thymidylate synthase inhibitor Thymitaq™ (nolatrexed dihydrochloride) given by 10-day oral administration
por: Jodrell, D I, et al.
Publicado: (1999)

Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer
por: Vermeulen, P B, et al.
Publicado: (1999)

Microsatellite instability in thyroid tumours and tumour-like lesions
por: Lazzereschi, D, et al.
Publicado: (1999)

Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase
por: Nicholson, K M, et al.
Publicado: (1999)

The treatment of Wilms' tumour: results of the United Kingdom Children's Cancer Study Group (UKCCSG) second Wilms' tumour study
por: Mitchell, C, et al.
Publicado: (2000)

Epithelial tumours of the thymus
por: Ruffié, P, et al.
Publicado: (2001)

Alteration of tumour response to radiation by interleukin-2 gene transfer
por: Lee, J, et al.
Publicado: (2000)

The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition
por: Webley, S D, et al.
Publicado: (2001)

Expression of high p53 levels in colorectal cancer: a favourable prognostic factor
por: Adrover, E, et al.
Publicado: (1999)

The effects of exogenous growth factors on matrix metalloproteinase secretion by human brain tumour cells
por: Rooprai, H K, et al.
Publicado: (2000)

Analysis of TSG101 tumour susceptibility gene transcripts in cervical and endometrial cancers
por: Chang, J-G, et al.
Publicado: (1999)

Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions
por: Miédougé, M, et al.
Publicado: (1999)

p53 mutations in urinary bladder cancer
por: Berggren, P, et al.
Publicado: (2001)

Impact of thymidine phosphorylase surexpression on fluoropyrimidine activity and on tumour angiogenesis
por: Marchetti, S, et al.
Publicado: (2001)

Mutational status of K- ras and TP53 genes in primary sarcomas of the heart
por: Garcia, J M, et al.
Publicado: (2000)

Thalidomide increases both intra-tumoural tumour necrosis factor-α production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid
por: Cao, Z, et al.
Publicado: (1999)

Malignant tumours of the salivary glands
por: Bensadoun, R J, et al.
Publicado: (2001)

Enhancement of chemotherapy by manipulation of tumour pH
por: Raghunand, N, et al.
Publicado: (1999)

Morphologies, dimensions and targets of gastric nitric oxide synthase neurons
por: Di Natale, Madeleine R., et al.
Publicado: (2022)

The expression profile for the tumour suppressor gene PTEN and associated polymorphic markers
por: Hamilton, J A, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_841so2hsh6r9h6vgnri001vq9h